Gyros Protein Technologies
Is this your company? Claim this profile
Excipients & Specialty Ingredients
Regulatory, Tech Transfer & Support Services
Company Overview
About
Gyros Protein Technologies is a pharmaceutical CDMO offering comprehensive services.
Key Expertise
Specialized in Quality Control, Stability Testing, Method Development
Therapeutic Areas
Cardiovascular
Endocrinology
Quick Facts
HQ:Sweden
Founded:2017
Employees:404
Capabilities & Services
Core Capabilities
- Sterile Injectable
- Sterile Fill/Finish
- Fill/Finish (Vials)
Types of Organization
GMP Manufacturing
Quality Systems
Regulatory Support
Dosage Forms
Cartridge / Pen
Containment Capabilities
OEB 4 (1-10 µg/m³)
Production Scales
Phase III Clinical Trials
Commercial Scale
Clinical
Markets Served
Global
Regulatory Approvals
Drug Approval JW481W
Health Canada · #APR-IJJNJU7B · 2020-05-01
Drug Approval JD2BMN
Health Canada · #APR-EVF2V9MH · 2018-06-01
Certifications
EMA GMP Certificate
European Medicines Agency
Cert #: CERT-S4A6HPVA
Issued: 2020-11-10
Expires: 2025-03-21
ISO 9001:2015
International Organization for Standardization
Cert #: CERT-BGT6CA7K
Issued: 2020-01-08
Expires: 2025-07-18
ISO 13485:2016
International Organization for Standardization
Cert #: CERT-9JRDKJE7
Issued: 2020-06-02
Expires: 2025-09-27
Loading CDMO intelligence...
Key facts about Gyros Protein Technologies
- Gyros Protein Technologies is headquartered in Sweden.
- Gyros Protein Technologies was founded in 2017.
- Gyros Protein Technologies has 404 employees.
- Gyros Protein Technologies's capabilities include Sterile Injectable, Sterile Fill/Finish and Fill/Finish (Vials).
Find CDMOs like Gyros Protein Technologies
Directory pages this company appears in, each with the full list of matching manufacturers.